Facing some resistance at around $7 if it can beat that then 8 is in play then no real big resistance till around 12 - big 44M DARPA contract is not hurting, did not beat earnings but forward look is positive

ULTA faired well what about ELF, should it be time for that long awaited bounce and gap fill?

The Israel-based biotechnology company on Wednesday announced preclinical test data showing its proprietary naloxone hydrogel adheres to nasal tissue longer than an approved intranasal naloxone spray currently on the market. Using an ex-vivo rabbit nasal mucosa model, researchers applied each formulation to mucosal tissue and washed it with Simulated Nasal Electrolyte Solution over a 30-minute period. See Also: These Healthcare Stocks Just Exploded In Momentum — Investors Are Taking Notice Compared with the commercial product, Polyrizon’s Trap and Target hydrogel showed higher fluorescence marker values, with differences reaching statistical significance (p < 0.0001, two-way ANOVA).

@Kim Babers I saw it presented as an extended period player on youtube and then started following at around 7 bucks bought in at the pre-market breakout from the volume and overnight news- crazy how stuff sometimes just falls from the sky like manna from heaven lol